[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra^® 2.0].

ABSTRACT:

SUBMITTER: Calabro GE 

PROVIDER: S-EPMC10079375 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature